Insider Buying: Retractable Technologies, Inc. (NYSEAMERICAN:RVP) Major Shareholder Acquires 156,070 Shares of Stock

Retractable Technologies, Inc. (NYSEAMERICAN:RVPGet Rating) major shareholder Braden Michael Leonard acquired 156,070 shares of the business’s stock in a transaction on Thursday, April 28th. The stock was acquired at an average cost of $3.58 per share, for a total transaction of $558,730.60. Following the transaction, the insider now directly owns 3,076,070 shares in the company, valued at $11,012,330.60. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Braden Michael Leonard also recently made the following trade(s):

  • On Monday, May 2nd, Braden Michael Leonard acquired 153,428 shares of Retractable Technologies stock. The shares were bought at an average price of $3.84 per share, with a total value of $589,163.52.

Retractable Technologies stock opened at $3.85 on Tuesday. The stock has a market cap of $127.52 million, a P/E ratio of 2.81 and a beta of 1.89. Retractable Technologies, Inc. has a 52 week low of $3.28 and a 52 week high of $13.91. The company has a current ratio of 2.44, a quick ratio of 1.92 and a debt-to-equity ratio of 0.02.

Retractable Technologies (NYSEAMERICAN:RVPGet Rating) last issued its quarterly earnings results on Thursday, March 31st. The company reported $0.61 earnings per share (EPS) for the quarter. The company had revenue of $59.46 million for the quarter. Retractable Technologies had a return on equity of 68.86% and a net margin of 28.99%.

Separately, TheStreet cut Retractable Technologies from a “b-” rating to a “c+” rating in a research note on Wednesday, January 5th.

A number of hedge funds have recently modified their holdings of RVP. Renaissance Technologies LLC purchased a new position in Retractable Technologies during the fourth quarter worth approximately $680,000. Allspring Global Investments Holdings LLC purchased a new position in shares of Retractable Technologies in the fourth quarter valued at approximately $530,000. Marshall Wace LLP lifted its position in shares of Retractable Technologies by 30.4% in the third quarter. Marshall Wace LLP now owns 219,504 shares of the company’s stock valued at $2,421,000 after acquiring an additional 51,134 shares in the last quarter. Morgan Stanley lifted its position in shares of Retractable Technologies by 239.8% in the second quarter. Morgan Stanley now owns 62,655 shares of the company’s stock valued at $724,000 after acquiring an additional 44,217 shares in the last quarter. Finally, Stone Asset Management Inc. purchased a new position in shares of Retractable Technologies in the fourth quarter valued at approximately $213,000. Institutional investors own 24.02% of the company’s stock.

Retractable Technologies Company Profile (Get Rating)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Recommended Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.